Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dow Chemical Co (DOW): Dan Loeb’s Proxy Fight Takes an Interesting Turn of Events

Dan Loeb‘s Third Point has taken some steps regarding Dow Chemical Co (NYSE:DOW) and has formed an advisory board that can help the company to seek measures to increase value. Third Point currently owns 22.0 million shares of the company, the stake amassing less than 2% of the company. The investor also launched a website,, where it will keep the public and other shareholders updated regarding the activity of the company and Third Point’s moves regarding the company.

Third Point

Third Point is the first investor to go activist on the company for more than a decade. Mr. Loeb initiated a position in Dow Chemical Co (NYSE:DOW) during the last quarter of 2013 and disclosed holding around 7.73 million shares. During the first quarter of 2014, the position was edged down by 7% on the quarter, but during the second quarter, Third Point boosted the stake to 22.0 million shares. The fund has not yet reported its equity portfolio for the third quarter and with the recent move, we might see the fund further raising its position. As of the end of the second quarter, Dow Chemical was the largest holding in Third Point’s equity portfolio.

On its new website, Third Point has accused the board of Dow Chemical Co (NYSE:DOW)of underperformance. Among the promises that the company has brokent, the investor mentioned $10 billion in adjusted EBITDA that the company has promised to reach every year since 2009. However, the company reported EBITDA of around $10.6 billion, although in the previous years this value was much much smaller (for example it amounted to $5.6 billion in 2012). Also among other things, the investor accused Dow Chemical of making excuses, while trying to justify why it failed to meet its targets. Dow Chemical has posted relatively solid returns over the last years. Its stock gained 70% since 2009 and the company has increased its dividend to $0.37 from $0.15 per share. However, as Third Point pointed out, the stock still underperformed in comparison with the S&P 500, which grew by 86% over the last five years.

In this way, Third Point considers that its new Advisory Board can help Dow Chemical Co (NYSE:DOW) to increase the value of the company and to outperform its peers by putting the interest of shareholders first. The board consists of two people: R. “Steve” Miller and Raymond J. Milchovich. Mr. Miller has been the chairman of American International Group Inc (NYSE:AIG) since 2010 and Mr. Milchovich is a former CEO of Foster Wheeler AG (NASDAQ:FWLT), serving between 2001 and 2011, during which he led the company through a restructuring process.

Among other shareholders of Dow Chemical Co (NYSE:DOW) is Daniel S. Och‘s OZ Management with around 9.31 million shares as of the end of June and Rob Citrone’s Discovery Capital Management, which increased its stake by 15% during the second quarter to some 9.17 million shares.

Dow Chemical Co (NYSE:DOW) has already issued a response to Third Point’s allegations and moves. The company said that it disagrees with the investor’s position and that its statements do not present a fundamental understanding of the company. Moreover, the company added that its board and management are taking steps that are aimed towards the best interest of long-term investors of the company.

Earlier, during an interview, Chairmand and CEO of Dow Chemical Co (NYSE:DOW), Andrew Liveris, has discussed Dan Loeb’s position and mentioned that the company had been in talks with Third Point, but it has not received any letters directly from them. However, Dow Chemical was one of the main points addressed in Third Point’s letter to investors for the first quarter.

With Mr. Loeb being a tenacious activist investor, who over the years has changed the performance of many companies, such as Yahoo! Inc. (NASDAQ:YHOO), where he contributed to some significant changes that had a positive impact on the company, the proxy fight with Dow Chemical will be an interesting one to follow.

Disclosure: none

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!